These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3284118)

  • 41. Cyclosporine treatment with conversion after three months is a safe treatment protocol in renal allograft recipients.
    Hoitsma AJ; Tiggeler RG; Wetzels JF; Berden JH; Koene RA
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):161-3. PubMed ID: 3291234
    [No Abstract]   [Full Text] [Related]  

  • 42. Cyclosporine nephrotoxicity: studies in laboratory animals.
    Sullivan BA; Hak LJ; Finn WF
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):145-54. PubMed ID: 3895655
    [No Abstract]   [Full Text] [Related]  

  • 43. Subcapsular interstitial fibrosis in kidneys of rats treated with cyclosporine for 16 weeks.
    Starklint H; Dieperink H; Kemp E; Leyssac PP
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):816-20. PubMed ID: 3388515
    [No Abstract]   [Full Text] [Related]  

  • 44. Analysis of the immunosuppressive and nephrotoxic effects of cyclosporin G.
    Hoyt EG; Hagberg RC; Billingham ME; Baldwin JC; Jamieson SW
    J Heart Transplant; 1988; 7(2):111-7. PubMed ID: 3284981
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ketoconazole and cyclosporine A: combined effects on rat renal function and on serum and tissue cyclosporine A concentration.
    Dieperink H; Kemp E; Leyssac PP; Starklint H; Wanscher M; Nielsen J; Jørgensen KA; Faber V; Flachs H
    Clin Nephrol; 1986; 25 Suppl 1():S137-43. PubMed ID: 3708923
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Conversion of long-term renal allograft recipients from prednisolone/azathioprine to cyclosporine monotherapy.
    Birkeland SA; Foged N; Kold AA; Svendsen V; Rohr N; Elbirk A
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):171-5. PubMed ID: 3291237
    [No Abstract]   [Full Text] [Related]  

  • 47. Chronic renal lesions in rats after long-term treatment with cyclosporine A.
    Bäckman L; Sundelin B; Bohman SO
    Transplant Proc; 1990 Feb; 22(1):133-4. PubMed ID: 2309285
    [No Abstract]   [Full Text] [Related]  

  • 48. The case against the indefinite use of cyclosporine.
    Myers BD; Newton L; Oyer P
    Transplant Proc; 1991 Feb; 23(1 Pt 1):41-2. PubMed ID: 1990570
    [No Abstract]   [Full Text] [Related]  

  • 49. Management of cyclosporine toxicity by reduced dosage and azathioprine.
    Griffith BP; Hardesty RL; Lee A; Trento A; Thompson ME; Shapiro AP; Bahnson HT
    J Heart Transplant; 1985; 4(4):410-3. PubMed ID: 3916516
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antithymocyte gamma globulin, low-dosage cyclosporine, and tapering steroids as an immunosuppressive regimen to avoid early kidney failure in heart transplantation.
    Deeb GM; Kolff J; McClurken JB; Dunn J; Balsara R; Ochs R; Badellino M; Hollander T; Eldridge C; Clancey M
    J Heart Transplant; 1987; 6(2):79-83. PubMed ID: 3305833
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cyclosporine-induced renal structural damage: influence of dosage, strain, age and sex with reference to the rat and guinea pig.
    Duncan JI; Thomson AW; Aldridge RD; Simpson JG; Whiting PH
    Clin Nephrol; 1986; 25 Suppl 1():S14-7. PubMed ID: 3708924
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Renal function in the immediate postoperative period after heart transplantation using very low initial doses of cyclosporin A].
    Cladellas M; Sánchez JM; Abadal ML; Ballester M; Obrador D; Amengual MJ; Quintana E; Net A; Cámara ML; Padró JM
    Rev Esp Cardiol; 1987; 40 Suppl 2():70-3. PubMed ID: 3331810
    [No Abstract]   [Full Text] [Related]  

  • 53. Is cyclosporine-associated nephrotoxicity progressive?
    Vanrenterghem Y; Waer M; Roels L; Lerut T; Michielsen P
    Transplant Proc; 1987 Oct; 19(5):4031-2. PubMed ID: 3313992
    [No Abstract]   [Full Text] [Related]  

  • 54. Cyclosporine timing and kidney damage.
    Hrushesky WJ
    N Engl J Med; 1985 Jul; 313(3):184. PubMed ID: 4010713
    [No Abstract]   [Full Text] [Related]  

  • 55. Nephrotoxicity of cyclosporine A in rats with a diminished renal function.
    Provoost AP; Kaptein L; Van Aken M
    Clin Nephrol; 1986; 25 Suppl 1():S162-7. PubMed ID: 3519023
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Modulation of host defenses by cyclosporine. Influence of the route of administration on the course of infection.
    Findon G; Miller TE
    Transplantation; 1988 Apr; 45(4):815-7. PubMed ID: 3358279
    [No Abstract]   [Full Text] [Related]  

  • 57. Clinical summation. An algorithm for the management of patients with cyclosporine-induced renal dysfunction.
    Kahan BD
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):303-8. PubMed ID: 3895669
    [No Abstract]   [Full Text] [Related]  

  • 58. Prevention of cyclosporine (CyA) nephrotoxicity by synthetic prostaglandins.
    Makowka L; Lopatin W; Gilas T; Falk J; Phillips MJ; Falk R
    Clin Nephrol; 1986; 25 Suppl 1():S89-94. PubMed ID: 3708941
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Optimization by timing of oral cyclosporine to prevent acute kidney allograft rejection in dogs.
    Cavallini M; Halberg F; Sutherland DE; Cornélissen G; Heil J; Najarian JS
    Transplantation; 1986 May; 41(5):654-7. PubMed ID: 3518168
    [No Abstract]   [Full Text] [Related]  

  • 60. Results of conversion immunosuppression in 193 cadaver and 42 living-related donor renal allografts.
    Jacobson JE; Pontin A; van Zyl-Smit R; Pascoe M; Cassidy MJ; Swanepoel CR
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):155-6. PubMed ID: 3291232
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.